CEO: | Stuart Ashman |
CFO: | Manprit Singh Randhawa |
Independent Non-Executive Director: | Catherine Denise Prescott |
Non-Executive Chairman: | Martin Braddock Hunt |
Non-Executive Dir: | Danielle Bekker |
Address: | The Core, Bath Lane, Newcastle Helix, Newcastle upon Tyne, United Kingdom, NE4 5TF |
Phone: | +44 191 495 7325 |
Website: | http://www.skinbiotherapeutics.com |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BF33H870 |
Currency | UK Pounds |
Share Price | 9.25p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 29.00 |
52 Week Low | 7.25 |
Volume | 236,233 |
Shares Issued | 200.38m |
Market Cap | £18.54m |
Beta | 0.01 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:18 | 70,000 @ 9.00p |
12:34 | 6,958 @ 9.00p |
12:34 | 15,000 @ 9.01p |
12:33 | 15,000 @ 9.06p |
12:31 | 25,000 @ 9.02p |
CEO | Stuart Ashman |
CFO | Manprit Singh Randhawa |
You are here: research